FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116490717> ?p ?o ?g. }

• W2116490717 endingPage "1016" @default.
• W2116490717 startingPage "1007" @default.
• W2116490717 abstract "The efficacy of EMG-biofeedback and low-frequency electrical stimulation for the treatment of anal incontinence has not been proven. Our purpose was to evaluate a novel therapeutic concept, termed triple target treatment, which combines amplitude-modulated medium-frequency stimulation and EMG-biofeedback.Patients with anal incontinence were randomly assigned to the triple target regimen or EMG-biofeedback alone for a 9-month treatment period in a multicenter randomized clinical trial with blinded observers (ClincialTrials.gov registration number NCT00525291). Primary end points were changes in the Cleveland Clinic score and the adapted St. Mark's (Vaizey) score at 9 months compared with baseline. Secondary end points included therapy acceptance and proportion of patients achieving continence or improvement in grade or frequency of incontinence.We enrolled 158 patients with anal incontinence. The median decrease in the Cleveland Clinic score from baseline to 9 months was 3 points greater for the triple target regimen than for EMG-biofeedback (95% CI, 1-4; P = .0024). The improvement was 8 points for the triple target regimen (95% CI, 7-9) and 5 points for EMG-biofeedback (95% CI, 4-7). Results were similar for the Vaizey score. Of patients treated for at least 3 months, continence was achieved by 50% of patients with the triple target regimen and 25.8% of those with EMG-biofeedback.The combination of amplitude-modulated medium-frequency electrostimulation with EMG-biofeedback in the triple target regimen is superior to EMG-biofeedback alone in the treatment of anal incontinence. Therapy programs for fecal incontinence are most effective if patients participate for longer than 2 to 3 months." @default.
• W2116490717 created "2016-06-24" @default.
• W2116490717 creator A5020606704 @default.
• W2116490717 creator A5021703828 @default.
• W2116490717 creator A5034990538 @default.
• W2116490717 creator A5036343670 @default.
• W2116490717 creator A5039626163 @default.
• W2116490717 creator A5070658742 @default.
• W2116490717 creator A5077509067 @default.
• W2116490717 creator A5081410913 @default.
• W2116490717 creator A5083880240 @default.
• W2116490717 creator A5088940544 @default.
• W2116490717 date "2010-07-01" @default.
• W2116490717 modified "2023-10-16" @default.
• W2116490717 title "Triple Target Treatment (3T) Is More Effective Than Biofeedback Alone for Anal Incontinence: The 3T-AI Study" @default.
• W2116490717 cites W1755786945 @default.
• W2116490717 cites W1987103568 @default.
• W2116490717 cites W1999992885 @default.
• W2116490717 cites W2011785045 @default.
• W2116490717 cites W2022893652 @default.
• W2116490717 cites W2026763172 @default.
• W2116490717 cites W2030150650 @default.
• W2116490717 cites W2034258078 @default.
• W2116490717 cites W2034783885 @default.
• W2116490717 cites W2042834504 @default.
• W2116490717 cites W2061093714 @default.
• W2116490717 cites W2070773344 @default.
• W2116490717 cites W2074892935 @default.
• W2116490717 cites W2078072020 @default.
• W2116490717 cites W2086099559 @default.
• W2116490717 cites W2089461775 @default.
• W2116490717 cites W2105327933 @default.
• W2116490717 cites W2106060788 @default.
• W2116490717 cites W2108203760 @default.
• W2116490717 cites W2108882655 @default.
• W2116490717 cites W2112442962 @default.
• W2116490717 cites W2112531513 @default.
• W2116490717 cites W2121723435 @default.
• W2116490717 cites W2121952506 @default.
• W2116490717 cites W2146252824 @default.
• W2116490717 cites W2155263484 @default.
• W2116490717 cites W2259666366 @default.
• W2116490717 cites W2417606545 @default.
• W2116490717 cites W2613181664 @default.
• W2116490717 cites W2791615973 @default.
• W2116490717 cites W2912323162 @default.
• W2116490717 doi "https://doi.org/10.1007/dcr.0b013e3181db7738" @default.
• W2116490717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20551752" @default.
• W2116490717 hasPublicationYear "2010" @default.
• W2116490717 type Work @default.
• W2116490717 sameAs 2116490717 @default.
• W2116490717 citedByCount "63" @default.
• W2116490717 countsByYear W21164907172012 @default.
• W2116490717 countsByYear W21164907172013 @default.
• W2116490717 countsByYear W21164907172014 @default.
• W2116490717 countsByYear W21164907172015 @default.
• W2116490717 countsByYear W21164907172016 @default.
• W2116490717 countsByYear W21164907172017 @default.
• W2116490717 countsByYear W21164907172018 @default.
• W2116490717 countsByYear W21164907172019 @default.
• W2116490717 countsByYear W21164907172020 @default.
• W2116490717 countsByYear W21164907172021 @default.
• W2116490717 countsByYear W21164907172022 @default.
• W2116490717 countsByYear W21164907172023 @default.
• W2116490717 crossrefType "journal-article" @default.
• W2116490717 hasAuthorship W2116490717A5020606704 @default.
• W2116490717 hasAuthorship W2116490717A5021703828 @default.
• W2116490717 hasAuthorship W2116490717A5034990538 @default.
• W2116490717 hasAuthorship W2116490717A5036343670 @default.
• W2116490717 hasAuthorship W2116490717A5039626163 @default.
• W2116490717 hasAuthorship W2116490717A5070658742 @default.
• W2116490717 hasAuthorship W2116490717A5077509067 @default.
• W2116490717 hasAuthorship W2116490717A5081410913 @default.
• W2116490717 hasAuthorship W2116490717A5083880240 @default.
• W2116490717 hasAuthorship W2116490717A5088940544 @default.
• W2116490717 hasBestOaLocation W21164907171 @default.
• W2116490717 hasConcept C126894567 @default.
• W2116490717 hasConcept C141071460 @default.
• W2116490717 hasConcept C168563851 @default.
• W2116490717 hasConcept C1862650 @default.
• W2116490717 hasConcept C2776377089 @default.
• W2116490717 hasConcept C2776813522 @default.
• W2116490717 hasConcept C2780691517 @default.
• W2116490717 hasConcept C2781112942 @default.
• W2116490717 hasConcept C2781413609 @default.
• W2116490717 hasConcept C71924100 @default.
• W2116490717 hasConceptScore W2116490717C126894567 @default.
• W2116490717 hasConceptScore W2116490717C141071460 @default.
• W2116490717 hasConceptScore W2116490717C168563851 @default.
• W2116490717 hasConceptScore W2116490717C1862650 @default.
• W2116490717 hasConceptScore W2116490717C2776377089 @default.
• W2116490717 hasConceptScore W2116490717C2776813522 @default.
• W2116490717 hasConceptScore W2116490717C2780691517 @default.
• W2116490717 hasConceptScore W2116490717C2781112942 @default.
• W2116490717 hasConceptScore W2116490717C2781413609 @default.
• W2116490717 hasConceptScore W2116490717C71924100 @default.
• W2116490717 hasIssue "7" @default.
• W2116490717 hasLocation W21164907171 @default.

• next